Blackmores Ltd - Company Profile
Powered by 
All the data and insights you need on Blackmores Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Blackmores Ltd Strategy Report
- Understand Blackmores Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Blackmores Ltd (Blackmores) is a provider of health supplements. The company offers an array of vitamins, minerals, herbal products and nutritional supplements. It offers products for digestive health, energy and exercise, eye health, men and women health, arthritis, bone and muscle pain, brain health, heart and circulation, cold, flu and immunity. It also offers products for pregnancy and preconception, stress relief, fish and nutritional oils, kids health, and infant nutrition categories. In addition, Blackmores offers natural pet health care products for digestive, wound, liver, joint, grooming, skin, heart, ear and health and vitality. The company has business presence in Australia, Thailand, Malaysia, New Zealand, China, Singapore, Indonesia, India, Japan, Hong Kong, South Korea, Taiwan and the UK. Blackmores is headquartered in Warriewood, New South Wales, Australia.
Headquarters
Australia
Address
20 Jubilee Avenue, Warriewood, Sydney, New South Wales, 2102
Website
www.blackmores.com.au
Telephone
61 8 00803760
No of Employees
1,200
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$487.7M
Blackmores Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Arthritis, Joint, Bone and Muscle Products | Naturopathic Advisory Services | BioCeuticals |
| Brain Health Products | Fusion Health | |
| Children's Health Products | Impromy | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Others | In April, the company received a takeover offer from Kirin Holdings for US$1.24 billion. |
| 2020 | Divestiture | In October, the company divest its Global Therapeutics business to McPherson’s Limited for AUD27 million. |
| 2019 | Acquisitions/Mergers/Takeovers | In October, the company acquired manufacturing facility in Braeside, Victoria, Australia. |
Competitor Comparison
| Key Parameters | Blackmores Ltd | Sigma Healthcare Ltd | Treasury Wine Estates Ltd | Clover Corp Ltd | AFT Pharmaceuticals (AU) Pty Ltd |
|---|---|---|---|---|---|
| Headquarters | Australia | Australia | Australia | Australia | Australia |
| City | Sydney | Melbourne | Melbourne | Melbourne | Sydney |
| State/Province | New South Wales | Victoria | Victoria | Victoria | New South Wales |
| No. of Employees | 1,200 | 156 | 2,500 | 56 | - |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Alastair Symington | Chief Executive Officer; Managing Director | Executive Board | 2019 | - |
| Patrick Gibson | Chief Financial Officer | Senior Management | 2022 | - |
| Jane Franks | Chief People Officer | Senior Management | 2018 | - |
| Cecile Cooper | Chief Governance Officer | Senior Management | 2021 | - |
| John Rosair | Chief Commercial Officer; Managing Director - Asia & Pacific | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward